tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Sarepta falls 9% after FDA plans to investigate death of boy who took Elevidys

In after-hours trading, shares of Sarepta (SRPT) are down 9% to $10.90.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1